Futaki K - Search Results

1

The C29-C34 parts of antitumor macrolide aplyronine A serve as versatile actin-affinity tags.

Utomo DH, Fujieda A, Tanaka K, Takahashi M, Futaki K, Tanabe K, Kigoshi H, Kita M. Utomo DH, et al. Among authors: futaki k. Chem Commun (Camb). 2021 Oct 12;57(81):10540-10543. doi: 10.1039/d1cc04259a. Chem Commun (Camb). 2021. PMID: 34553712

2

Synthesis and Biological Activities of Aplyronine A Analogues toward the Development of Antitumor Protein-Protein Interaction Inducers between Actin and Tubulin: Conjugation of the C1-C9 Macrolactone Part and the C24-C34 Side Chain.

Futaki K, Takahashi M, Tanabe K, Fujieda A, Kigoshi H, Kita M. Futaki K, et al. ACS Omega. 2019 May 16;4(5):8598-8613. doi: 10.1021/acsomega.9b01099. eCollection 2019 May 31. ACS Omega. 2019. PMID: 31459949 Free PMC article.

3

Applicative Characteristics of a New Zirconia Bracket with Multiple Slots.

Maki K, Futaki K, Tanabe S, Takahashi M, Ichikawa Y, Yamaguchi T. Maki K, et al. Among authors: futaki k. Int J Dent. 2016;2016:4348325. doi: 10.1155/2016/4348325. Epub 2016 Apr 24. Int J Dent. 2016. PMID: 27212948 Free PMC article.

4

Medical emergency education using a robot patient in a dental setting.

Tanzawa T, Futaki K, Kurabayashi H, Goto K, Yoshihama Y, Hasegawa T, Yamamoto M, Inoue M, Miyazaki T, Maki K. Tanzawa T, et al. Among authors: futaki k. Eur J Dent Educ. 2013 Feb;17(1):e114-9. doi: 10.1111/j.1600-0579.2012.00770.x. Epub 2012 Jul 11. Eur J Dent Educ. 2013. PMID: 23279398

5

Introduction of a robot patient into dental education.

Tanzawa T, Futaki K, Tani C, Hasegawa T, Yamamoto M, Miyazaki T, Maki K. Tanzawa T, et al. Among authors: futaki k. Eur J Dent Educ. 2012 Feb;16(1):e195-9. doi: 10.1111/j.1600-0579.2011.00697.x. Epub 2011 Jul 14. Eur J Dent Educ. 2012. PMID: 22251346

6

Pyoderma gangrenosum associated with Takayasu's arteritis without typical symptoms.

Futaki K, Komine M, Hosoda S, Hirashima M, Yokokura H, Yamada T, Murata S, Matsuyama Y, Nagashima T, Nara H, Minota S, Ohtsuki M. Futaki K, et al. Eur J Dermatol. 2009 May-Jun;19(3):266-7. doi: 10.1684/ejd.2009.0635. Epub 2009 Feb 17. Eur J Dermatol. 2009. PMID: 19220980 No abstract available.

7

The FLT3 inhibitor PKC412 exerts differential cell cycle effects on leukemic cells depending on the presence of FLT3 mutations.

Odgerel T, Kikuchi J, Wada T, Shimizu R, Futaki K, Kano Y, Furukawa Y. Odgerel T, et al. Among authors: futaki k. Oncogene. 2008 May 15;27(22):3102-10. doi: 10.1038/sj.onc.1210980. Epub 2007 Dec 10. Oncogene. 2008. PMID: 18071308

8

Stability of fat-soluble and water-soluble vitamins in artificially prepared, vitamin-enriched, lyophilized serum.

Ihara H, Hashizume N, Matsubayashi T, Futaki K, Yoshida M, Sagawa N, Fujisaki M, Mita K, Kadota A. Ihara H, et al. Among authors: futaki k. J Clin Lab Anal. 2004;18(4):240-6. doi: 10.1002/jcla.20030. J Clin Lab Anal. 2004. PMID: 15202117 Free PMC article.

9

Development of a syngenic brain-tumor model resistant to chloroethyl-nitrosourea using a methylguanine DNA methyltransferase cDNA.

Manome Y, Watanabe M, Futaki K, Ishiguro H, Iwagami S, Noda K, Dobashi H, Ochiai Y, Ohara Y, Sanuki K, Kunieda T, Ohno T. Manome Y, et al. Among authors: futaki k. Anticancer Res. 1999 Nov-Dec;19(6B):5313-8. Anticancer Res. 1999. PMID: 10697554

10

Syntheses of striazolidino-[1,2-alpha]-s-triazolidine-3,7-dithione derivatives.

FUTAKI K, TOSA S. FUTAKI K, et al. Chem Pharm Bull (Tokyo). 1958 Feb;6(1):58-64. doi: 10.1248/cpb.6.58. Chem Pharm Bull (Tokyo). 1958. PMID: 13537152 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters